MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Social Network Structure and Caregiving Experiences in South Asian Families Living with Dementia Associated with Parkinsonian Disorders

    A. Oberoi, S. Gaur, C. Yang, G. Pal (New Brunswick, USA)

    Objective: To characterize social network structure and caregiving among SA families with Parkinsonian dementia (PD) and compare them with White American (WA) caregiving networks. Background:…
  • 2026 International Congress

    Multimodal Elastography-Assisted Quantitative Evaluation Tool for Diagnosing Rigidity in Parkinson’s Disease

    J. Zhao, S. Ma, Z. Wan, C. Shi (Beijing, China)

    Objective: To investigate the feasibility of multimodal elastography for quantifying rigidity in PD and to screen for diagnostically valuable muscle indicators to construct a non-invasive…
  • 2026 International Congress

    Deep Learning-Enhanced Multimodal MRI for Real-World Differentiation of Parkinsonian Disorders

    S. Hartono, H. Ulfah, Q. Sun, C. Liu, D. Patidar, P. Seow, P. Chai, Q. Lyu, R. Chen, E. Tan, L. Chan (Singapore, Singapore)

    Objective: To develop and evaluate an integrated, deep learning (DL)-enhanced multimodal MRI classification model combining nigrosome-1 (N1), neuromelanin (NM), free-water DTI (FW-DTI) and morphometry (MORPHO)…
  • 2026 International Congress

    Disassembly of α-Synuclein Aggregates by the All-D-peptide PRI-101: Preclinical Efficacy in Vitro and in Vivo.

    M. Sevenich, M. Feja, J. Jarazo, S. Reithofer, K. Korostov, S. Schemmert, F. Charbgoo, M. Wendt, G. Tamgüney, J. Schwamborn, F. Richter, D. Willbold, A. Willuweit (40225, Germany)

    Objective: To develop a disease-modifying therapy for Parkinson’s disease (PD) and related synucleinopathies by eliminating intracellular, toxic, and seeding-competent aggregate species of α-synuclein (α-syn). Background:…
  • 2026 International Congress

    Diagnosis and therapeutic approaches for sialorrhea in patients with Parkinson’s disease.

    N. Fedotova, E. Bril, O. Turgunkhujaev, O. Zimnyakova (Moscow, Russian Federation)

    Objective: To study the frequency of drooling complaints in Parkinson's disease (PD) patients during outpatient visits. Background: Sialorrhea (excessive drooling) is a non-motor symptom of…
  • 2026 International Congress

    Diagnostic Accuracy of NPH by Radiographic Suspicion and Effect on Patient Outcomes

    S. Yee, J. Miller, L. Acosta (Washington, USA)

    Objective: Our study examines the radiographic accuracy when suggesting normal pressure hydrocephalus (NPH), correlation with imaging study indication, and frequency of lumbar puncture (LP) for…
  • 2026 International Congress

    Early Manifestations of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) Include Dystonic Laryngeal Phenomena

    O. Chan, N. Simon, S. Tisch (Sydney, Australia)

    Objective: To describe four patients in whom laryngeal dystonia manifesting as cough and spasmodic dysphonia preceded Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)…
  • 2026 International Congress

    GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes

    KA. Woo, Y. Jang, P. Park, HJ. Kim (Seoul, Republic of Korea)

    Objective: We tested whether interindividual differences in systemic GLP1R expression are associated with PDRD risk among adults with type 2 diabetes initiating GLP-1RAs. Background: Preclinical…
  • 2026 International Congress

    Motor and Quality‑of‑Life Outcomes After MR‑Guided Focused Ultrasound Subthalamotomy for Parkinson’s Disease: A Meta‑analysis

    A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the efficacy and safety of MR guided focused ultrasound (MRgFUS) subthalamotomy for improving motor symptoms, medication burden, and quality of life inParkinson’s…
  • 2026 International Congress

    Ante-Mortem Motor Speech Profiles in Postmortem Confirmed Atypical Parkinsonisms

    N. Herndon, B. Patel, K. Hegland, O. Carranza-Renteria, S. Prokop (Gainesville, USA)

    Objective: Differences in motor speech profiles may aid in diagnosis of atypical parkinsonisms. This is a retrospective study that characterizes ante-mortem motor speech profiles in postmortem…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley